Drug Industry Must Consider Teens’ “Risk-Taking” Nature – Researcher
This article was originally published in The Tan Sheet
Executive Summary
Limits on adolescents' access to potentially harmful products because of the high-risk behaviors associated with the age group should be considered, according to psychology researcher Laurence Steinberg, who will speak at FDA's public workshop on adolescents' decision making skills and their use of over-the-counter drug products
You may also be interested in...
Door Opened On Revising Labeling For Teens, But FDA Not Anxious To Enter
FDA executives and researchers are recommending the agency and the drug industry improve drug labels so younger consumers can understand how to safely and effectively use the products. However, some experts say revised labels will not stop adolescents who want to abuse OTC drugs
Door Opened On Revising Labeling For Teens, But FDA Not Anxious To Enter
FDA executives and researchers are recommending the agency and the drug industry improve drug labels so younger consumers can understand how to safely and effectively use the products. However, some experts say revised labels will not stop adolescents who want to abuse OTC drugs
Door Opened On Revising Labeling For Teens, But FDA Not Anxious To Enter
FDA executives and researchers are recommending the agency and the drug industry improve drug labels so younger consumers can understand how to safely and effectively use the products. However, some experts say revised labels will not stop adolescents who want to abuse OTC drugs